By Catherine Bertram
In Gaithersburg, Maryland, on July 15 and 16, an FDA panel will hear testimony about the effects that cigarette mint flavoring may have on health. Menthol will be the first matter taken up by the FDA’s new Tobacco Products Scientific Advisory Committee. To see the agenda for the meetings and for emails and phone numbers related to these meetings click here.
Menthol cigarettes make up approximately a third of the US market. It is expected that various experts will testify about possible health risks associated with menthol and whether menthol increases cigarette addiction. Based on the panel’s recommendations, the FDA will consider whether to ban or limit tobacco products which contain menthol.